Answers are grounded in this paper and cite their sources.
COMISA is a common disorder that results in nighttime awakenings ,daytime sleepiness and PAP intolerance. Cognitive behavioral therapy for insomnia is used to improve PAP adherence and no medication has been evaluated in such population yet. Melatonin with its chronobiotic and antioxidant effects may have potential benefits on COMISA consequences at the appropriate dose and time. This study aimed to evaluate the effect of melatonin on sleep quality, daytime sleepiness and PAP Compliance in patients with COMISA.
No takes yet. Share an insight, caveat, or question.
Motlaq et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: